Trial intelligence / Profile preview

Effects of Droxidopa on Gait, Kyphosis, and Reach in Parkinson's Disease

NCT03173781Completed

Sponsor
Colorado Springs Neurological Associates
Start
Apr 2016
Primary completion
Oct 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised trial in Parkinson's disease (PD) comparing droxidopa with placebo (2 arms). Primary endpoints: 10 Meter Walk Test at 24 months and Dual Task Timed Up and Go test at 24 months. Started Apr 2016; status: completed.

02

Drugs

droxidopa
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NCT03173781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03173781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call